Literature DB >> 7679510

Stimulation of T cells by antigenic peptide complexed with isolated chains of major histocompatibility complex class II molecules.

B Nag1, H G Wada, S V Deshpande, D Passmore, T Kendrick, S D Sharma, B R Clark, H M McConnell.   

Abstract

Major histocompatibility complex (MHC) class II molecules are heterodimeric glycoproteins with one alpha and one beta polypeptide chain of similar molecular size. In this report, we describe the binding of an acetylated N-terminal peptide of myelin basic protein, [Ala4]MBP-(1-14), to purified individual alpha and beta chains of murine I-Ak molecules. Purified complexes of isolated single chains and antigenic peptide bind to cloned T cells restricted by I-Ak and [Ala4]MBP-(1-14) tetradecapeptide. The binding is blocked by alpha/beta anti-T-cell receptor (TCR) monoclonal antibody. Cell triggering as measured by an increase in extracellular acidification rate is observed when cloned T cells are exposed to purified complexes of isolated chains and antigenic peptide. This increase in the extracellular acidification rate is antigen specific and MHC-restricted, as chains alone or irrelevant chain-peptide complexes do not trigger an increase in the metabolic acidification rate. These results together demonstrate that in vitro cloned T cells are triggered by complexes of specific antigenic peptides and isolated individual chains of their cognate MHC proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679510      PMCID: PMC45923          DOI: 10.1073/pnas.90.4.1604

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  In vitro maximum binding of antigenic peptides to murine MHC class II molecules does not always take place at the acidic pH of the in vivo endosomal compartment.

Authors:  B Nag; D Passmore; S V Deshpande; B R Clark
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

2.  IL-2 secretion and T cell clonal anergy are induced by distinct biochemical pathways.

Authors:  S D Norton; D E Hovinen; M K Jenkins
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

3.  Reactions of the subunits of the class II major histocompatibility complex molecule IAd.

Authors:  R Tampé; D Tyvoll; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

4.  Continuous monitoring of receptor-mediated changes in the metabolic rates of living cells.

Authors:  J C Owicki; J W Parce; K M Kercso; G B Sigal; V C Muir; J C Venter; C M Fraser; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  Specific binding of antigenic peptides to separate alpha and beta chains of class II molecules of the major histocompatibility complex.

Authors:  B Rothenhäusler; K Dornmair; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  Cell surface expression of the amino-terminal domain of A kappa alpha. Recognition of an isolated MHC antigenic structure by allospecific T cells but not alloantibodies.

Authors:  J McCluskey; T Munitz; L Boyd; R N Germain; J E Coligan; A Singer; D H Margulies
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

7.  Detection of cell-affecting agents with a silicon biosensor.

Authors:  J W Parce; J C Owicki; K M Kercso; G B Sigal; H G Wada; V C Muir; L J Bousse; K L Ross; B I Sikic; H M McConnell
Journal:  Science       Date:  1989-10-13       Impact factor: 47.728

8.  Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein.

Authors:  C B Davis; D J Mitchell; D C Wraith; J A Todd; S S Zamvil; H O McDevitt; L Steinman; P P Jones
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

9.  Novel methods to rapidly and sensitively analyze antigenic peptide binding to MHC class II molecules.

Authors:  B Nag; S V Deshpande; B R Clark
Journal:  J Immunol Methods       Date:  1991-08-28       Impact factor: 2.303

10.  Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention.

Authors:  H Acha-Orbea; D J Mitchell; L Timmermann; D C Wraith; G S Tausch; M K Waldor; S S Zamvil; H O McDevitt; L Steinman
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

View more
  5 in total

1.  Induction of T cell anergy by liposomes with incorporated major histocompatibility complex (MHC) II/peptide complexes.

Authors:  A J van Rensen; L S Taams; M C Grosfeld-Stulemeyer; W van Eden; D J Crommelin; M H Wauben
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

2.  Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activity.

Authors:  Jianya Y Huan; Roberto Meza-Romero; Jeffery L Mooney; Yuan K Chou; David M Edwards; Cathleen Rich; Jason M Link; Arthur A Vandenbark; Dennis N Bourdette; Hans-Peter Bächinger; Gregory G Burrows
Journal:  J Chem Technol Biotechnol       Date:  2004-10-12       Impact factor: 3.174

Review 3.  Synthetic peptides in biochemical research.

Authors:  D C Hancock; N J O'Reilly; G I Evan
Journal:  Mol Biotechnol       Date:  1995-08       Impact factor: 2.695

4.  Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases.

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; M Takaono; K Iwasaki; M Kinoshita; M Sumiya
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

5.  Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.

Authors:  M W Nicolle; B Nag; S D Sharma; N Willcox; A Vincent; D J Ferguson; J Newsom-Davis
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.